COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Study to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C Reduction

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03549260
Recruitment Status : Completed
First Posted : June 7, 2018
Last Update Posted : February 18, 2019
Medpace, Inc.
Information provided by (Responsible Party):
LIB Therapeutics LLC

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 9, 2018
Actual Study Completion Date : November 30, 2018